Literature DB >> 27882466

Frequency of 3' VNTR Polymorphism in the Dopamine Transporter Gene SLC6A3 in Humans Predisposed to Antisocial Behavior.

E V Cherepkova1, L I Aftanas2, N Maksimov3,4, P N Menshanov4,5.   

Abstract

Predisposition to antisocial behavior can be related to the presence of certain polymorphic variants of genes encoding dopaminergic system proteins. We studied the frequencies of allele variants and genotypes of variable number tandem repeat polymorphism in 3' untranslated region (3' VTNR) of the dopaminergic transporter SLC6A3 gene in Caucasian men committed socially dangerous violent and non-violent crimes. Alleles with 9 and 10 repeats were most frequent in both the control group and group of men predisposed to antisocial behavior. At the same time, the 10/10 genotype was more frequently observed in the group of men prone to antisocial non-violent behavior. Hence, the presence of certain variants of 3' VTNR polymorphism of SLC6A3 gene in men is associated with predisposition to certain forms of antisocial behavior.

Entities:  

Keywords:  3’ VNTR polymorphism; SLC6A3; antisocial behavior; case–control study; dopamine transporter

Mesh:

Substances:

Year:  2016        PMID: 27882466     DOI: 10.1007/s10517-016-3551-7

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  2 in total

1.  Genetically-Driven Enhancement of Dopaminergic Transmission Affects Moral Acceptability in Females but Not in Males: A Pilot Study.

Authors:  Silvia Pellegrini; Sara Palumbo; Caterina Iofrida; Erika Melissari; Giuseppina Rota; Veronica Mariotti; Teresa Anastasio; Andrea Manfrinati; Rino Rumiati; Lorella Lotto; Michela Sarlo; Pietro Pietrini
Journal:  Front Behav Neurosci       Date:  2017-08-29       Impact factor: 3.558

Review 2.  22q11.2 duplication: a review of neuropsychiatric correlates and a newly observed case of prototypic sociopathy.

Authors:  Sonam Vyas; John N Constantino; Dustin Baldridge
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-12-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.